204 related articles for article (PubMed ID: 28073228)
41. Lipid-lowering treatment in peripheral artery disease.
Katsiki N; Giannoukas AD; Athyros VG; Mikhailidis DP
Curr Opin Pharmacol; 2018 Apr; 39():19-26. PubMed ID: 29413998
[TBL] [Abstract][Full Text] [Related]
42. How well tolerated are lipid-lowering drugs?
Tomlinson B; Chan P; Lan W
Drugs Aging; 2001; 18(9):665-83. PubMed ID: 11599634
[TBL] [Abstract][Full Text] [Related]
43. Managing the underestimated risk of statin-associated myopathy.
Rallidis LS; Fountoulaki K; Anastasiou-Nana M
Int J Cardiol; 2012 Sep; 159(3):169-76. PubMed ID: 21813193
[TBL] [Abstract][Full Text] [Related]
44. Management of statin-intolerant patient.
Arca M; Pigna G; Favoccia C
Panminerva Med; 2012 Jun; 54(2):105-18. PubMed ID: 22525565
[TBL] [Abstract][Full Text] [Related]
45. Tolerability of red yeast rice (2,400 mg twice daily) versus pravastatin (20 mg twice daily) in patients with previous statin intolerance.
Halbert SC; French B; Gordon RY; Farrar JT; Schmitz K; Morris PB; Thompson PD; Rader DJ; Becker DJ
Am J Cardiol; 2010 Jan; 105(2):198-204. PubMed ID: 20102918
[TBL] [Abstract][Full Text] [Related]
46. Statin intolerance: now a solved problem.
Sikka P; Kapoor S; Bindra VK; Sharma M; Vishwakarma P; Saxena KK
J Postgrad Med; 2011; 57(4):321-8. PubMed ID: 22120862
[TBL] [Abstract][Full Text] [Related]
47. [Statin intolerance and statin-associated muscular pain].
Stürzebecher PE; Schumann F; Kassner U; Laufs U
Herz; 2022 Jun; 47(3):204-211. PubMed ID: 35451596
[TBL] [Abstract][Full Text] [Related]
48. Expert opinion: the therapeutic challenges faced by statin intolerance.
Patel J; Martin SS; Banach M
Expert Opin Pharmacother; 2016 Aug; 17(11):1497-507. PubMed ID: 27254275
[TBL] [Abstract][Full Text] [Related]
49. [Statin-induced adverse effects -- facts and genes].
Harangi M; Zsíros N; Juhász L; Paragh G
Orv Hetil; 2013 Jan; 154(3):83-92. PubMed ID: 23315223
[TBL] [Abstract][Full Text] [Related]
50. Statin Intolerance From a Clinician's Perspective.
Whayne TF
Angiology; 2016 Mar; 67(3):205-7. PubMed ID: 26019266
[No Abstract] [Full Text] [Related]
51. Efficacy and tolerability of fluvastatin XL 80 mg alone, ezetimibe alone, and the combination of fluvastatin XL 80 mg with ezetimibe in patients with a history of muscle-related side effects with other statins.
Stein EA; Ballantyne CM; Windler E; Sirnes PA; Sussekov A; Yigit Z; Seper C; Gimpelewicz CR
Am J Cardiol; 2008 Feb; 101(4):490-6. PubMed ID: 18312764
[TBL] [Abstract][Full Text] [Related]
52. Risk identification and possible countermeasures for muscle adverse effects during statin therapy.
Magni P; Macchi C; Morlotti B; Sirtori CR; Ruscica M
Eur J Intern Med; 2015 Mar; 26(2):82-8. PubMed ID: 25640999
[TBL] [Abstract][Full Text] [Related]
53. [Autoimmune myopathy associated with statin use].
Ljøstad U; Mygland Å
Tidsskr Nor Laegeforen; 2016 Sep; 136(16):1360-2. PubMed ID: 27637055
[TBL] [Abstract][Full Text] [Related]
54. Current overview of statin-induced myopathy.
Rosenson RS
Am J Med; 2004 Mar; 116(6):408-16. PubMed ID: 15006590
[TBL] [Abstract][Full Text] [Related]
55. Statin Intolerance: A Review and Update.
Tsushima Y; Hatipoglu B
Endocr Pract; 2023 Jul; 29(7):566-571. PubMed ID: 36958647
[TBL] [Abstract][Full Text] [Related]
56. [ACUTE CORONARY SYNDROME AND LIPID-LOWERING THERAPY. DOES THE IMPROVE-IT STUDY MAKE ANY DIFFERENCE?].
Lancellotti P; Pierard LA; Scheen AJ
Rev Med Liege; 2015 Sep; 70(9):450-5. PubMed ID: 26638446
[TBL] [Abstract][Full Text] [Related]
57. [Muscle-related adverse effects of statins].
Pohjola-Sintonen S; Julkunen H
Duodecim; 2014; 130(16):1622-7. PubMed ID: 25269368
[TBL] [Abstract][Full Text] [Related]
58. Statin use and its association with musculoskeletal symptoms--a cross-sectional study in primary care settings.
Mosshammer D; Lorenz G; Meznaric S; Schwarz J; Muche R; Mörike K
Fam Pract; 2009 Apr; 26(2):88-95. PubMed ID: 19233960
[TBL] [Abstract][Full Text] [Related]
59. Statin induced myopathy.
Frank RE
J Insur Med; 2009; 41(2):132-5. PubMed ID: 19845216
[TBL] [Abstract][Full Text] [Related]
60. Statin myopathy: significant problem with minimal awareness by clinicians and no emphasis by clinical investigators.
Whayne TF
Angiology; 2011 Jul; 62(5):415-21. PubMed ID: 21421631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
